Catalent To Expand Its Biologics Analytical Services With New Facility In Durham, North Carolina
December 15, 2022
December 15, 2022
SOMERSET, New Jersey, Dec. 15 -- Catalent Inc., a pharma, biotech and consumer health company, issued the following news on Dec. 14, 2022:
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it is to establish a new biologics analytical center of excellence in Durham, within North Carolina's Research Triangle, to offer . . .
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it is to establish a new biologics analytical center of excellence in Durham, within North Carolina's Research Triangle, to offer . . .